Pomerantz LLP Investigates Humana Inc. Securities Claims

Pomerantz LLP is leading an investigation into possible securities fraud and other unlawful business practices by Humana Inc. and its officers. This comes after the US Department of Justice filed a False Claims Act complaint against Humana and others, alleging that the company paid illegal kickbacks to brokers in exchange for enrollments into Medicare Advantage plans. As a result, Humana's stock price plummeted by 2.36% to close at $256.04 per share on May 1, 2025.

Key Takeaways:

• Pomerantz LLP is investigating claims of securities fraud and other unlawful business practices by Humana Inc. and its officers.
• The US Department of Justice filed a False Claims Act complaint against Humana, alleging that the company paid illegal kickbacks to brokers from 2016 to 2021.
• Humana's stock price fell by 2.36% to $256.04 per share on May 1, 2025, after the DOJ's lawsuit announcement.
• The Pomerantz firm has offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, and is acknowledged as a premier firm in corporate, securities, and antitrust class litigation.
• The firm was founded by Abraham L. Pomerantz, a pioneer in the field of securities class actions, and has recovered numerous multimillion-dollar damages awards on behalf of class members.

Statistics:

• $6.20: The amount Humana's stock price fell per share on May 1, 2025.
• 2.36%: The percentage decrease in Humana's stock price on May 1, 2025.
• 2016-2021: The period during which Humana allegedly paid illegal kickbacks to brokers, according to the False Claims Act complaint.
• $256.04: Humana's stock price on May 1, 2025, after the announcement of the DOJ's lawsuit.

Sources:

• Pomerantz LLP
• US Department of Justice
• New York Stock Exchange (NYSE)